Inhibiting specific protein action could lead to precision therapy for some patients with drug-resistant leukemia
Medical Xpress
NOVEMBER 7, 2024
Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent among East Asians that contributes to drug resistance, driving the aggressive growth of cancer cells in patients with chronic myeloid leukemia.
Let's personalize your content